The Invisible Infrastructure of Health: Rewiring the Menopause Conversation

DELHI, India – June 09, 2026

My work typically involves deconstructing the invisible networks that define our future—the fiber optic cables, the 5G signals, the AI-driven grids that form the digital backbone of our cities. We analyze the infrastructure that enables autonomous vehicles and sustainable megaprojects. But recently, a press release about Women’s Health Awareness Month prompted me to consider a different, far more ancient, and profoundly personal network: the intricate, often misunderstood biological system of the female body. Specifically, the universal yet frequently silenced transition of menopause.

This isn't a story about smart cars; it's about the intelligent systems that have governed human health for millennia. The conversation was sparked by Menoveda, a Delhi-based wellness brand. While its focus is on Ayurvedic remedies for perimenopause and menopause, its story reveals a fascinating blueprint for how ancient knowledge networks are integrating with modern global commerce and scientific validation, creating a new kind of infrastructure for health and empowerment. It’s a case study not just in wellness, but in how cultural knowledge flows, how markets respond to systemic gaps, and how a personal struggle can scale into a global movement.

A Systemic Gap in Health Infrastructure

For decades, the global health infrastructure has had a significant blind spot. Menopause, a natural biological process that will be experienced by over a billion women by 2025, has been treated less as a life stage and more as an afterthought, shrouded in silence and stigma. This isn't just a social issue; it's a systemic failure. The global menopause market, valued at over $15 billion and projected to surpass $24 billion by 2030, is booming precisely because conventional systems have left so many women feeling underserved.

"Many women feel their symptoms are dismissed or that the only option is hormone therapy, which they may not want or be able to take," notes one women's health specialist. This gap has created a powerful demand for alternatives. The market data is clear: dietary supplements make up over 90% of the menopause market, a testament to the widespread search for non-hormonal, natural solutions. North America may currently lead this market, but the demand is global, and the solutions are increasingly coming from unexpected corners of the world.

This is the landscape into which Menoveda entered in 2022. Founded by Tamanna Singh after her own "personal struggle with perimenopause," the company's mission goes beyond commerce. "We've done more than launch a product line," Singh stated in a release. "With Menoveda, we've created a movement to support underserved women silently going through the misunderstood transition of menopause." Her words frame the problem not as a medical deficiency in women, but as a support deficiency in the world around them.

Integrating Ancient and Modern Networks

The core of Menoveda's architecture lies in its ambitious integration of two powerful, yet historically separate, knowledge networks: the 5,000-year-old system of Ayurveda and the modern framework of clinical science. Ayurveda views menopause not as a disease, but as a natural transition into the Vata-dominant stage of life, where qualities of air and space (dryness, instability, coolness) can become aggravated. The goal isn't to fight the transition but to balance the body's internal network—the doshas—through diet, lifestyle, and herbal remedies.

Menoveda's innovation is to translate this holistic philosophy into products that meet modern expectations of safety and efficacy. While the company markets its formulations as "science-backed" and using "clinically approved ingredients," the real power lies in the centuries of empirical data supporting its core components. Herbs like Ashwagandha, Shatavari, and Brahmi are staples in Ayurvedic practice for managing stress, hormonal balance, and cognitive function. Recent systematic reviews and randomized controlled trials have begun to validate these ancient uses within the Western scientific paradigm, showing significant improvements in menopausal symptoms with minimal side effects.

This approach directly challenges the rigid separation between "traditional" and "scientific" medicine. It proposes that the most robust network is a hybrid one. By packaging Ayurvedic wisdom in clinically tested, hormone-free, vegan formulations, the company is building a bridge for consumers who are intrigued by holistic wellness but also demand a certain level of scientific assurance. It's a strategic move that acknowledges a global user base fluent in the language of both ancient tradition and modern data.

Building a New Global Wellness Corridor

Menoveda’s story is also a fascinating example of a new global network taking shape, where wellness innovations flow not just from West to East, but in all directions. Singh refers to her company's solution as "'India's gift to empower women around the world.'" This isn't just marketing rhetoric; it reflects a broader trend of Indian brands leveraging the country's deep well of traditional knowledge to compete on the international stage.

The infrastructure enabling this is twofold. First, there's the digital backbone I so often write about. E-commerce platforms, social media, and digital education allow a brand from Delhi to speak directly to a woman in Florida, creating a global community and supply chain that would have been unimaginable a generation ago. Menoveda offers not just products but "diagnosis support and educational material," building a support ecosystem that transcends geography.

Second, there is a growing global "soft power" infrastructure for wellness. As consumers worldwide become more sophisticated and skeptical of one-size-fits-all solutions, they are increasingly open to diverse philosophies of health. The rise of yoga, meditation, and now Ayurveda in the West is not a fad but a fundamental shift in the global wellness market. Menoveda is riding this wave, positioning itself as an authentic and accessible conduit for this ancient knowledge. This represents a new kind of global trade—not just in goods, but in entire systems of well-being.

Normalization as Social Infrastructure

Ultimately, the most profound network Menoveda aims to build is a human one. The goal to "normalize menopause" is an act of constructing social infrastructure. Just as roads and bridges connect cities, open conversations and shared knowledge connect people, reducing isolation and building collective resilience. When a life stage is shrouded in silence, it becomes a private burden. When it is normalized, it becomes a shared journey.

"Menopause should never be invalidating," Singh insists. "It's part of what makes us women, and we should be able to find the support necessary to help us succeed during this time of life as much as any other."

This drive to create a supportive community and a new narrative is perhaps the most critical piece of the puzzle. It transforms customers into members of a movement and turns a product into a platform for change. By weaving together the threads of biology, ancient wisdom, modern science, and global commerce, the company is doing more than selling supplements. It is helping to design and build a more robust, resilient, and inclusive network of support for women everywhere.